image
ANI Pharmaceuticals, Inc. ANIP
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 56.58
-3.96 %
$ 1.19 B
Market Cap
-120.38
P/E
INCOME STATEMENT
487 M REVENUE
53.87%
Growth Rates
1Year 53.87%
3Years 32.67%
5Years 19.28%
7Years 20.94%
10Years 32.10%
47 M OPERATING INCOME
287.40%
Growth Rates
1Year 287.40%
3Years 70.13%
5Years 5.84%
7Years 12.91%
10Years 48.54%
18.8 M NET INCOME
139.21%
Growth Rates
1Year 139.21%
3Years 41.49%
5Years 3.92%
7Years 25.02%
10Years 51.19%
EFFICIENCY
Earnings Waterfall ANI Pharmaceuticals, Inc.
image
Revenue 487 M
Cost Of Revenue 182 M
Gross Profit 305 M
Operating Expenses 196 M
Operating Income 47 M
Other Expenses 28.2 M
Net Income 18.8 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
REVENUE
Revenue 486.8 316.4 216.1 208.5 206.5 201.6 176.8 128.6 76.3 56.0 30.1 2.3 0.4 2.5 1.3 3.8 0.5 14.4 0.3 77.9 K 65.5 K 2.8 1.7 2 1 0.1
GROSS PROFIT
Cost Of Revenue 181.5 138.8 100.6 87.2 63.2 73.0 79.0 48.8 12.7 11.5 10.0 9.2 50 K 0.3 0 0 0 0 0 0 0 0 0 24.3 K 0 0
Gross Profit 305.3 177.6 115.5 121.3 143.4 128.6 97.8 79.8 63.6 44.5 20.1 (6.9) 0.4 2.2 1.3 3.8 0.5 14.4 0.3 77.9 K 65.5 K 2.8 1.7 24.3 K 1 0.1
OPERATING INCOME
Operating Expenses 196.0 203.3 143.7 136.9 127.0 93.2 68.6 53.1 30.9 24.5 19.2 25.5 51.3 45.8 39.7 21.8 9.2 11.0 9.6 12.3 6.1 6.6 4.5 3.7 1.6 2.8
Selling, General and Administrative Expenses 161.7 124.0 84.3 65.0 55.8 44.1 31.6 27.8 21.2 17.9 16.4 8.2 7.0 5.9 5.7 6.0 4.3 7.0 3.1 3.1 2.3 1.8 2.3 1.7 0.9 1.1
Research and Development Expenses 34.3 22.3 11.4 16.0 19.8 15.4 9.1 2.9 2.9 2.7 1.7 16.9 44.2 39.7 13.7 15.8 4.8 3.9 6.4 9.2 3.7 4.8 2.1 1.9 0.7 1.4
Operating Income 47.0 (25.1) (32.5) (16.1) 16.4 35.4 28.3 20.1 32.7 20.0 0.9 (23.2) (50.9) (43.6) (38.4) (18.0) (8.7) 3.4 (9.3) (12.3) (6.0) (3.8) (2.8) (3.7) (1.6) (2.7)
PRE-TAX INCOME
Interest Income Expense 26.9 28.1 11.9 9.5 13.0 14.8 12.0 11.3 11.0 0.8 0.5 0.3 0.7 0.7 0.1 0 0 0 0 0 0 0 0 0 0 0
Total Other Income (27.1) (27.4) (16.3) (9.9) (13.2) (15.3) (12.0) (11.4) (11.0) (0.6) (0.8) (5.6) (0.7) (2.6) (9.1) (17 407.2) (7 575.8) (1.1) (0.3) 0.3 86.6 K 0 0.2 0 0 0
Pre-Tax Income 19.9 (62.7) (56.1) (26.0) 3.2 20.1 16.3 8.7 21.7 19.4 0.1 (27.8) (51 608.5) (46 196.2) (47 527.8) (17 425.2) (7 584.4) 2 791.3 (9 651.0) (12.0) (6.0) (3.8) (2.6) 0 0 0
NET INCOME
Tax Provision 1.1 (14.8) (13.5) (3.4) (2.9) 4.6 17.4 4.7 6.4 (9.4) 20 K (0.1) 0.7 2.6 9.1 (17 407.8) (7 576.9) 0.6 0.3 0 0 0 0 (0.2) (0.2) 0
Net Income 18.8 (47.9) (42.6) (22.5) 6.1 15.5 (1.1) 3.9 15.4 28.7 0.3 (27.7) (51.6) (46.2) (47.5) (17.4) (7.6) 2.8 (9.7) (12.0) (6.0) (3.8) (2.6) (3.4) (1.4) (2.7)
EPS 0.95 2.95 3.38 1.88 0.51 1.33 0.0932 0.34 1.34 2.61 0.92 7.64 18.9 25.2 50.4 23 10.7 4.68 17.9 25.2 19.4 18.3 14.5 21.5 10.2 27.5